Dichloromethane → (E)-3-{4-[2-(4-Methyl-piperazin-1-yl)-2-oxo-ethyl]-2-oxo-2,3,4,5-tetrahydro-1H-pyrido[2,3-e][1,4]diazepin-7-yl}acrylic acid hydrochloride
反応式
Br[C:2]1[CH:23]=[N:22][C:5]2[NH:6][C:7](=[O:21])[CH2:8][N:9]([CH2:11][C:12]([N:14]3[CH2:19][CH2:18][N:17]([CH3:20])[CH2:16][CH2:15]3)=[O:13])[CH2:10][C:4]=2[CH:3]=1.[C:24]([O:28]C(C)(C)C)(=[O:27])[CH:25]=[CH2:26].C(N(C(C)C)C(C)C)C.CC1C=CC=CC=1P(C1C=CC=CC=1C)C1C=CC=CC=1C.C(Cl)[Cl:65]>C(#N)CC.CN(C=O)C.CC([O-])=O.CC([O-])=O.[Pd+2]>[ClH:65].[CH3:20][N:17]1[CH2:18][CH2:19][N:14]([C:12](=[O:13])[CH2:11][N:9]2[CH2:10][C:4]3[CH:3]=[C:2](/[CH:26]=[CH:25]/[C:24]([OH:28])=[O:27])[CH:23]=[N:22][C:5]=3[NH:6][C:7](=[O:21])[CH2:8]2)[CH2:15][CH2:16]1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 3
実験手順
A suspension of 7-Bromo-4-[2-(4-methyl-piperazin-1-yl)-2-oxo-ethyl]-1,3,4,5-tetrahydro-pyrido[2,3-e][1,4]diazepin-2-one (1.39 g, 3.64 mmol) in propionitrile (32 mL) and DMF (8 mL) was de-oxygenated with Ar for 15 min. The mixture was treated with tert-butyl acrylate (2.1 mL, 14 mmol) and (i-Pr)2EtN (1.3 mL, 7.4 mmol) and then was de-oxygenated with Ar for 10 min. Pd(OAc)2 (83 mg, 0.37 mmol) and P(o-tol)3 (0.22 g, 0.73 mmol) were added simultaneously, and the mixture was de-oxygenated a third time for 10 min. The mixture was heated to reflux overnight, then allowed to cool. The resulting precipitate was isolated by filtration and dissolved in CH2Cl2. The solution was filtered through Celite and the solvent was removed in vacuo to give the title compound (1.13 g, 72%) as an off-white solid: MS (ESI) m/e 430 (M+H)+.
後処理
- waitwas de-oxygenated with Ar for 10 min
- customfor 10 min
- temperatureThe mixture was heated
- temperatureto reflux overnight
- temperatureto cool
- customThe resulting precipitate was isolated by filtration
- filtrationThe solution was filtered through Celite
- customthe solvent was removed in vacuo
出典と根拠
- ORDレコード
- ord-88720258b9354494b852440be1d03834
- 出典データセット
- uspto-grants-2010_09
- 特許番号
- US07790709B2
反応ノート
読み込み中…